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he present study aims to evaluate the antioxidant and anxiolytic-like efect of Tualang honey in stressed ovariectomized (OVX)
rats. he animals were divided into; (i) nonstressed sham-operated control rats, (ii) sham-operated control rats exposed to stress,
(iii) nonstressed OVX rats, (iv) OVX rats exposed to stress, (v) OVX rats exposed to stress and treated with 17 �-oestradiol
(E2) (20 �g daily, sc), and (vi) OVX rats exposed to stress and treated with Tualang honey (0.2 g/kg body weight, orally). he
open ield test was used to evaluate the anxiety-like behaviour and ELISA kits were used to measure oxidant/antioxidant status
of the brain homogenates. he result showed that anxiety-like behavior was signiicantly increased in stressed OVX compared
to other groups, and administering either E2 or Tualang honey signiicantly decreased anxiety-like behaviour in stressed OVX
rats. he levels of malondialdehyde (MDA) and protein carbonyl (PCO) were signiicantly decreased while the levels/activities of
superoxide dismutase (SOD), glutathione S-transferases (GST), glutathione peroxidase (GPx), and glutathione reductase (GR)
were signiicantly increased in the brain homogenates of treated stressed OVX groups compared to untreated stressed OVX.
In conclusion, Tualang honey has protective efects against brain oxidative stress and may be useful alternative anxiolytic agent
especially for postmenopausal women.
1. Introduction
Oxidative stress is deined as an imbalance between increased
reactive oxygen species (ROS) production and inadequate
antioxidant defense, a condition characterised by an overload
in oxidants, which may culminate in cellular dysfunction
[1]. Previous studies have demonstrated that oxidative stress
is involved in aging and age-related processes that oten
accompany menopause [2–4].
he involvement of oxidative stress in neurodegenerative
[5, 6] and psychiatric disorders [7], including anxiety [8]
has gained particular interest, as the brain is considered
especially sensitive to oxidative damage for a number of
reasons [5]. he brain consumes considerable amount of
oxygen and therefore produces comparatively large amount
of free radical by-products, while having relatively modest
antioxidant defenses. In addition, the brain is rich in lipid
substrates for oxidation, as well as iron and copper ions that
catalyse free radical reactions [5].
Mitochondrial dysfunction, inlammation, alterations in
glutamate or gamma-aminobutyric acid (GABA) signalling,
and inhibition of neurogenesis may contribute to increased
oxidative stress, resulting in damage to cellular macro-
molecules. Eventually, the consequences are increased apop-
tosis, neuronal degeneration, and brain damage, leading to
the manifestation of neuropsychiatric illnesses in susceptible
individuals [9].
Previous studies observe a close relationship between
oxidative stress and anxiety in both human patients suf-
fering from anxiety disorders (obsessive-compulsive and
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panic disorders), and humans and animals displaying high
trait anxiety [10, 11]. Studies have also focused on the link
between redox status and normal anxiety, as well as on the
possible causal relationship between cellular oxidative stress
and emotional stress [12, 13].
Stress and oestrogen (E2) deiciency are the major
contributors in increasing an individual’s susceptibility to
oxidative stress and afective disorders. Recently, our research
group reported increased anxiety-like behavior in stressed
ovariectomized (OVX) rats compared with nonstressed OVX
or stressed sham-operated controls [14]. It was suggested that
high circulating corticosterone acts synergistically with low
circulating E2 to exert negative efects on the mood.
Studies have reported the beneicial efects of E2 [15–
18] and dietary antioxidants including honey as therapeutic
or preventive approach to health and mood disorders [19].
Malaysian Tualang honey is a pure, wild multiloral honey
produced by Asian rock bees, Apis dorsata [20]. he bees
build immense honeycombs on branches of very tall Tualang
trees (Koompassia excelsa) in the Rain Forest of Northern
Peninsular Malaysia [21]. Tualang honey is reported to have
the highest antiradical activity compared to Gelam honey,
Indian forest honey, and Pineapple honey [22]. Honey has
been shown to reduce oxidative stress in animals [21, 23–
25]. Study by our research group revealed that Tualang
honey reduces oxidative stress in postmenopausal women
[26]. Based on the above information, we hypothesised that
Tualang honey, through its antioxidant efect, modulates
anxiety-like behavior in stressed OVX rats.
he aims of this study were to evaluate the efects of
Tualang honey supplementation on anxiety-like behavior and
the brain antioxidant/oxidant system and to compare them
with E2 treatment in stressed OVX rats.
2. Materials and Methods
2.1. Animals. Sixty adult females and 3 adult males Sprague-
Dawley rats aged approximately 8weeks oldwith bodyweight
of 200 ± 20 g were obtained from the Animal Research and
Service Centre (ARASC), Universiti Sains Malaysia (USM),
Malaysia. All rats were housed in polypropylene cages (32 ×
24 × 16 cm), exposed to 12 hr light-dark cycles, maintained at
a room temperature of 23∘C, and provided with free access
to food and water. he cage bedding was changed every
two days. he experimental protocol was approved by the
Research and Animal Ethics Committee, USM.
he rats were randomly divided into six groups (� = 10
per group) as follows: (i) nonstressed sham-operated control
rats; (ii) sham-operated control rats exposed to stress; (iii)
nonstressed and OVX rats; (iv) OVX rats exposed to stress;
(v)OVX rats exposed to stress and treatedwith 17�-E2 (20�g
daily, sc), and (vi) OVX rats exposed to stress and treatedwith
Tualang honey (0.2 g/kg body weight, orally).
2.2. Surgical Procedure. Ovariectomy was performed under
general anaesthesia following an intraperitoneal injection of
60mg/kg of ketamine and 5mg/kg of xylazine. he dorsal
lumbar fur was shaved and cleaned with chlorhexidine
scrub and 70% ethanol. A small 2 cm midline incision was
made on the dorsal area over the 3rd to the 5th lumbar
vertebrae. he ovarian fat pad was gently grasped using
forceps and the ovary was exposed and removed. Following
bilateral ovariectomy, the peritoneal cavity and skin were
closed using absorbable sutures. he entire procedure was
performed using aseptic technique. Ater the operation,
animals were maintained under a heat lamp for one hour to
avoid hypothermia. Sham-operated rats underwent a similar
procedure, but without resection of the ovaries. Following
surgery, animals were housed separately in clean cages for 10
days to avoid any interactions that might cause bleeding or
poor healing. Ater 10 days, animals were then housed in a
group of three per cage for two months.
2.3. Animal Treatment. he rats were treated with either
20�g/day 17�-oestradiol (Cayman Chemical, Ann Arbor,
MI, USA) in 2.5 �L corn oil injected subcutaneously [27] or
0.2 g/kg body weight/day of Tualang honey (Agro Mas, Fed-
eral Agricultural Marketing Authority (FAMA), Mergong,
Kedah, Malaysia) diluted with 1mL of distilled water and
administered orally by gavage [28]. he treatments were
started three days prior to stress procedures and continued
throughout the 15 days of stress procedures.
2.4. Social Instability Stress Procedure. he social instability
stress procedure was conducted two months ater ovariec-
tomy [29–32]. he procedure consisted of alternate isolation
and crowding phases for 15 days as previously described [33].
he experiment started and ended with an isolation phase,
with each phase lasting 24 hrs. Eight rats (threemales and ive
females)were held per cage for the crowding phase.he initial
30min of each crowding phase was videotaped. Biting attacks
and dominant postures while ighting for food were counted
[34, 35].
2.5. Behavioural Assessment. he open ield test (OFT) was
performed ater the social instability stress procedure. he
test was performed during the dark phase in a ventilated
and soundproofed room that was maintained at a constant
temperature of 23∘C. he lighting intensity was maintained
at a constant lux throughout the procedure with two 150-watt
lamps.
he OFT arena consisted of a 35 cm high transparent
plastic wall and a loor with a surface area of 120 × 120 cm2.
White lines were drawn on the loor dividing the surface
into 16 equal squares [36]. hree luorescent lights provided
difuse overhead illumination.he animals were tested in the
quiet room, and locomotive activity over a 5min period was
recorded using a digital camcorder placed at a control panel
stationed 5m from the testing apparatus for behavioural
analysis later. Between each rat, the apparatus was cleaned
with 70% alcohol to eliminate possible bias due to the odour
that could have been let by the previous subject.
Recorded video was later scored by an experienced
observerwhowas blinded to the condition of the animals.he
mean number or duration of the following parameters was
scored: (i) movement including rearing events (number of
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Table 1: Efects of OVX and stress on anxiety-like behaviour.
Duration (seconds) Number
Grooming Crossing the lines Freezing Face washing Total rearing Boli
Sham-operated control
No stress 47.37 ± 1.48 104.01 ± 1.6 67.12 ± 1.89 3.00 ± 0.18 7.11 ± 0.93 1.66 ± 0.23
Stress 55.37 ± 0.68 99.89 ± 1.98 70.25 ± 1.22 3.12 ± 0.23 6.25 ± 0.65 2.02 ± 0.18
OVX
No stress 54.87 ± 0.98 86.01 ± 0.85 81.37 ± 1.19 3.57 ± 0.26 4.75 ± 0.25 3.25 ± 0.26
Stress 65.32 ± 0.81 69.23 ± 0.98 90.81 ± 1.05 3.63 ± 0.21 4.37 ± 0.18 4.12 ± 0.23
Stress efect � < 0.001 � < 0.001 � < 0.001 � > 0.05 � < 0.01 � < 0.01
OVX efect � < 0.001 � < 0.001 � < 0.001 � > 0.05 � < 0.001 � < 0.001
Stress X OVX interaction � < 0.01 � < 0.01 � < 0.01 � > 0.05 � < 0.05 � < 0.05
Note: Values are expressed as mean ± SEM. Two-way ANOVAwere utilised to examine the efects of stress (stress versus no stress) and surgery (sham-operated
versus OVX) on anxiety-like behaviour. � < 0.05 indicates signiicant diference.
vertical activity), freezing time (seconds), and grooming time
(seconds); (ii) locomotive activity, that is, time spent crossing
the line (seconds); (iii) autonomic nervous system responses
including defaecation (number of faecal boli) and number of
face-washing events.
2.6. Blood Collections. he animals were sacriiced by decap-
itation immediately ater the OFT. A total of 10mL of blood
was collected immediately via cardiac puncture. All blood
samples were let to clot for 2 hours prior to centrifugation
for 15min at 4000 rpm (EBA 21, Hettich GmbH & Co. KG,
Tuttlingen, Germany). Approximately 3mL of serum was
collected and stored at –20∘C until assay.
2.7. Estimation of Serum Oestradiol and Corticosterone Levels.
Serum oestradiol and corticosterone levels were measured
using a speciic ELISA kit (Creative Diagnostics, Shirley, NY,
USA) according to the manufacturer’s instructions. Briely,
100 �L of serum sample was added to each well followed
by 100 �L of enzyme-labelled oestradiol/corticosterone. he
plate was incubated at 37∘C for 90min. Following incubation,
the wells were carefully washed and 100 �L of biotin-antibody
working solution was added to each well and then incubated
at 37∘C for 60min. Following three washes, 100 �L of HRP
was added to eachwell and then incubated at 37∘C for 30min.
Next, 100 �L of TMBReagentwas added to eachwell and then
incubated at room temperature for 20min, which resulted
in a colour change. he colour change was stopped with the
addition of 100 �L of stop solution. he absorbance was then
measured at 450 nm using a spectrophotometer (hermo
Fisher Scientiic Inc. Waltham, MA, USA).
2.8. Preparation of Brain Homogenate. Brains from each
group were quickly removed and carefully dissected in ice-
cold saline to separate the brain hemispheres. he isolated
hemispheres were then weighed and a homogenate (10%w/v)
was prepared from the let hemisphere in ice-cold 0.1M
phosphate-bufered saline (PBS, pH 7.4), whereas the right
hemisphere was kept for histological study.he homogenates
were then centrifuged with speed centrifugation (10,000 ×g)
for 10min. he samples were kept at −80∘C until assay.
2.9. Assay of Antioxidant and Oxidative Stress Biomarkers.
Commercially available kits were used to determine the
level of superoxide dismutase (SOD), glutathione perox-
idase (GPx) activity, glutathione reductase (GR) activity,
glutathione S-transferases (GST), malondialdehyde (MDA),
and total antioxidant capacity (TAC) (Northwest Life Science
Specialties, Vancouver, USA) as well as the levels of catalase
(CAT) and carbonyl proteins (PCO) (Cayman Chemical,
Ann Arbor, MI, USA) in the brain homogenate. he total
protein concentration was detected based on the Bradford
method [37].
2.10. Statistical Analysis. Data were analysed using Predictive
Analytics Sotware (PASW) version 20.0. Two-way analyses
of variance (ANOVA) was utilised to examine the efects of
stress (stress versus no stress) and surgery (sham-operated
versus OVX) on anxiety-like behaviour. One-way ANOVA
followed by post-hoc Tukey test was utilised to evaluate the
efects of TH and oestradiol on anxiety-like behaviour, stress
hormone level, and brain oxidative stress level/activity. Data
were presented as themean± standard error ofmeans (SEM).
Probability values of less than 5% (� < 0.05) were considered
statistically signiicant.
3. Results
3.1. Anxiety-Like Behaviour. he two-way ANOVA results on
the efects of surgery and stress on anxiety-like behavior are
summarised in Table 1. here was a signiicant main efect
of stress on most of the anxiety-like behavior such as the
total rearing number, grooming, time spent crossing the lines,
freezing time, and number of boli.he change in anxiety-like
behaviors was signiicantly higher in the stress than in the
nonstressed rats.
Our data also indicated a signiicant main efect of
surgery on most of the anxiety-like behaviors such as total
rearing number, grooming, time spent crossing the lines,
freezing time, and number of boli.he change in anxiety-like
behaviors was signiicantly greater in OVX rats than in sham-
operated control rats.
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here was signiicant interaction between stress andOVX
on most of the anxiety-like behaviors such as total rearing
number, grooming, time spent crossing the lines, freezing
time, and number of boli, indicating that sham-operated
control and OVX rats were afected diferently by stress.
Most of the anxiety-like behavior was signiicantly increased
following stress.
he one-way ANOVA revealed that the mean number of
rearing events (F(5, 54) = 13.72, P < 0.001), freezing time
(F(5, 54) = 35.27, P < 0.001), grooming time (F(5, 54) =
37.87, P < 0.001), time spent crossing the line (F(5, 54) =
16.73, P < 0.001), and the number of boli (F(5, 54) = 18.49,
P < 0.001) were signiicantly diferent between the groups.
However, there was no signiicant diference (P < 0.05) in the
mean number of face washing between the groups as shown
in Figure 1.
he post hoc analysis revealed signiicant increase in the
mean number of rearing events and time spent crossing the
line, and signiicant decrease in the mean grooming time and
the number of boli in stressed OVX treated with either E2 or
Tualang honey when compared to untreated stressed OVX
rats. Both E2 and Tualang honey signiicantly increased the
mean number of rearing events and time spent crossing the
lines, and signiicantly decreased the mean grooming time
and the number of boli of treated stressed OVX comparable
to that of sham-operated control rats.
he post hoc analysis showed that the mean freezing
timewas signiicantly decreased in stressedOVX treatedwith
either E2 or Tualang honey (P < 0.05) compared to untreated
stressed OVX. Both E2 and Tualang honey reduced the mean
freezing time of treated stressed OVX comparable to that of
nonstressedOVX but the values remained higher than that of
sham-operated control rats.
3.2. Serum Oestradiol and Corticosterone Levels. he serum
level of oestradiol was signiicantly higher in sham-operated
when compared with OVX groups except for OVX rats
treated with 17 �-oestradiol (230.10 ± 11.29 versus 81.80
± 2.91 pg/mL; P < 0.05). Meanwhile, serum corticosterone
levels were signiicantly lowered in nonstressed compared to
stressed rats (4611.00 ± 169.43 versus 5661.90 ± 163.95 pg/mL;
P < 0.05).
3.3. Brain Oxidant/Antioxidant Status. he present study
showed signiicant diferences among the groups in the mean
activity/level of SOD (F(5, 54) = 26.75, P < 0.001), CAT (F(5,
54) = 9.17, P < 0.001), GR (F(5, 54) = 9.61, P < 0.05), GPx (F(5,
54) = 16.75, P < 0.001), GST (F(5, 54) = 26.51, P < 0.001), TAC
(F(5, 54) = 5.95, P < 0.001), MDA (F(5, 56) = 9.55, P < 0.001),
and PCO (F(5, 56) = 33.08, P < 0.001) as shown in Figure 2.
Both E2 and Tualang honey increased the mean activ-
ity/level of GR, GST, and TAC and reduced the mean
activity/level of CAT, PCO, and MDA comparable to that of
sham-operated control rats. he mean activity/level of SOD
and GPx of treated stressed OVX rats was also signiicantly
increased but the values remained lower than that of sham-
operated control rats.
4. Discussion
We found that the anxiety-like behavior was signiicantly
increased in stressed rats compared to nonstressed rats. Our
results were also consistent with those of previous animal
studies that reported decreased activity in an open ield
following predator (cat) exposure stress [38] and chronic
restraint stress [39, 40]. Previous studies also revealed that
chronic stress or chronically elevated levels of glucocorticoids
exert detrimental efects on the brain and behavior [41, 42].
However, our data were inconsistent with previous studies
that found increased locomotion and reduced defecation
scores [43, 44] or no change [45] following chronic social
isolation stress. his inconsistency may be attributed to
methodological diferences. It is possible that the crowding
phase and not the isolation phase contributes to anxiety-like
behaviors.
he present study also found increased anxiety-like
behavior in OVX rats compared to sham-operated controls.
his inding was in parallel with previous animal studies [46–
48]. Galeeva and Tuohimaa [46] found that exploration of
open arms is reduced in diestrous females, suggesting that
female mice are more anxious when their E2 levels are low.
Previous studies revealed that OVX rats exhibit high anxiety-
like behavior compared to sham-control rats [47, 49]. A
recent study by Daendee et al. [48] examined anxiety-like
behavior with elevated T-maze (ETM) and open ield 7, 14,
21, and 28 days ater OVX. hey found increased anxiety as
shownby increase in inhibitory avoidance latency in the ETM
with signiicant efect at day 21 and even higher at day 28.
Human studies also documented that women are 1.5 times
more likely than men to exhibit social anxiety-like disorder.
his vulnerability to anxiety-like disorders in women has
been attributed to low levels of E2 and progestin [50–52].
Interestingly, a signiicant decrease in the overall anxiety-
like behavior was noted in stressed OVX rats treated with
either E2 or Tualang honey for 18 days compared to untreated
rats. he overall improvements in anxiety-like behavior are
comparable with that of nonstressed sham-operated rats
and are in line with those of previous animal studies [49,
53, 54]. Mora et al. [55] reported greater percentage of
time spent in the open arms indicating reduced anxiety-like
behavior in E2 benzoate-treated OVX rats compared with
vehicle-treated female rats. Furthermore, clinical studies also
reported that E2 replacement therapy in postmenopausal
women is associated with improved anxiety and depression
symptoms [56–58].
he efects of E2, however, have been reported to be dose
and duration dependent. Very low or high dosages of E2,
which is not expected to signiicantly increase the circulating
E2 concentrations to the levels observed in naturally receptive
rats, result in only slight or no decrease in anxiety-like
behavior [59, 60]. In addition, chronic E2 treatment is
necessary to elicit more stable efects on anxiety-like behavior
because various doses of acute E2 treatment have been shown
not to afect anxiety-like behavior [59].Morgan and Pfaf [44]
suggested that the increased anxiety-like behavior in OVX
mice treated with 25 �g/day of E2 benzoate for 5 weeks is due
to the increase in arousal process.
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Figure 1: Efects of Tualang honey and E2 on anxiety-like behaviour. (a) Mean rearing number was signiicantly increased in stressed OVX
rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (b) Mean freezing time (s) was signiicantly decreased
in stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (c) Mean grooming time (s) was
signiicantly decreased in stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (d) Mean
duration of crossing line (s) was signiicantly increased in stressedOVX rats treated with either E2 or Tualang honey compared with untreated
stressed OVX. (e) Mean number of boli rearing number was signiicantly decreased in stressed OVX rats treated with either E2 or Tualang
honey compared with untreated stressed OVX. (f) Mean number of face washing was not signiicantly diferent between the experimental
groups.he data are shown as means ± S.E.M. ∗P < 0.05 ∗∗P < 0.001 denote signiicantly diferent values from stressed OVX group. #P < 0.05
##P < 0.001 denote signiicantly diferent values from nonstressed sham-operated control group.
Antioxidant properties of E2 have been suggested to
improve hippocampal and cortical histology by reducing
brain lipid peroxidation [61]. Our group recently reported
that E2 treatment in stressed OVX rats enhanced neuronal
proliferation of hippocampal CA2, CA3, and DG regions
compared to untreated stressed OVX rats [62]. In the present
study, we found higher activities of SOD, GST, GPx, and
GR in the brain homogenates of E2-treated group compared
with untreated stressed OVX rats and these indings possibly
explain the improvement in hippocampus morphology in
our previous reports [62]. Chronic E2 treatment triggers
signiicant increase in GST and GR activities in the aorta
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Figure 2: Efects of Tualang honey and E2 on brain oxidant/antioxidant level/activity. (a) Mean SOD activity was signiicantly increased in
stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (b) Mean CAT activity was signiicantly
decreased in stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (c) Mean GR activity was
signiicantly increased in stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (d) Mean GPx
activity was signiicantly increased in stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed OVX. (e)
Mean GST activity was signiicantly increased in stressed OVX rats treated with either E2 or Tualang honey compared with untreated stressed
OVX. (f) Mean TAC level was signiicantly increased in stressed OVX rats treated with either E2 or Tualang honey compared with untreated
stressed OVX. (g) Mean PCO level was signiicantly decreased in stressed OVX rats treated with either E2 or Tualang honey compared with
untreated stressed OVX. (h) Mean MDA level was signiicantly decreased in stressed OVX rats treated with either E2 or Tualang honey
compared with untreated stressed OVX. he data are shown as means ± S.E.M. ∗P < 0.05 ∗∗P < 0.001 denote signiicantly diferent values
from stressed OVX group. #P < 0.05 ##P < 0.001 denote signiicantly diferent values from nonstressed sham-operated control group.
of OVX rabbit compared with the untreated group [63].
Increased SOD and GPX activity, decreased MDA, and
reduced PCO were also observed in OVX rats receiving
chronic E2 treatment [64–66]. A recent study by Ceravolo
et al. [67] also found that chronic conjugate equine E2
therapy signiicantly enhances CAT expression in OVX rats
compared to untreated rats. In addition, clinical studies
noted higher CAT [26], GPx [26], SOD [68], and TAC
[69] activities/levels in postmenopausal women treated with
chronic HRT.
he antioxidative activities of E2 possibly act via two
diferent mechanisms. he irst mechanism is by using the
hydroxyphenolic structure of E2 as an important free-radical
scavenger [69] independent of the ER activation [61, 70].
Modiication or removal of the phenolic group blocks the
antioxidant activities of E2 [71]. he second mechanism is
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related to the inluence of E2 on endogenous antioxidative
enzyme systems [68]. E2 is highly lipid soluble and largely
resides in the membrane component of cells [72], where they
are ideally suited to afect the oxidation of unsaturated bonds
in phospholipids. his membrane localisation allows E2 to
interact synergistically with abundant antioxidants, such as
glutathione [73, 74]. Another study revealed that E2 can
prevent lipid peroxidation by sacriicing itself, resulting in a
quinol product [75].
However, our data were inconsistent with that of a
previous clinical study which showed no signiicant dif-
ference in SOD level between HRT-treated and untreated
postmenopausal women [76], as well as an animal study that
showed reduced GPx activities in both plasma and brain
tissues of OVX rats treated with chronic E2 combinations
[77]. hese discrepancies could possibly be due to E2 efects
being less prominent at older age group or act diferently in
human and animal.
Interestingly, our study also revealed that chronic Tualang
honey supplementation in stressed OVX rats produced anx-
iolytic efects comparable to E2. Our inding supports an
earlier study showing decreased anxiety-like behavior in rats
fed with 10%, 20%, and 40% honey compared with those fed
with either sucrose or sugar-free diets [19]. A recent study
conducted by Oyekunle et al. [78] also found that female rats
fedwith 20% and 40%bee honey concentrations demonstrate
anxiolytic-like efects that are attributed to the antioxidant
properties of pure bee honey. In addition, other antioxidant
compounds such as rosmarinic acid, zingicomb, chlorogenic
acid, and Withania somnifera are able to reduce anxiety-
like behavior in rats and mice [79–82]. Bhattacharya et al.
[79] suggested that Withania somnifera, an antioxidant diet,
increases the activities of antioxidant enzymes in rat brain
frontal cortex and striatum and thus reduces anxiety-like
behaviour. It is also possible to suggest that Tualang honey
reduces the brain oxidative stress that in turn modulates the
brain 5-HT system and reduces anxiety-like behaviour.
In conclusion, Tualang honey supplementation has pro-
tective efects against brain oxidative stress and anxiety-like
behavior comparable to E2 treatment in stressed OVX rats.
his efect possibly works through improvement in brain
oxidant/antioxidant status and modulation of the brain 5-
HT system. We therefore propose that Tualang honey is an
alternative anxiolytic agent especially for postmenopausal
women. However, further conirmatory studies are required
to determine its usage as an anxiolytic agent in anxiety
disorders and its clinical efective dose.
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